CoChat

A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States

Werner, Erika F., Hauspurg, Alisse K., Rouse, Dwight J. · 2015 · Obstetrics & Gynecology

The DOI matches its Crossref record; 76 of the 82 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To develop a decision model to evaluate the risks, benefits, and costs of different approaches to aspirin prophylaxis for the approximately 4 million pregnant women in the United States annually. METHODS: We created a decision model to evaluate four approaches to aspirin prophylaxis in the United States: no prophylaxis, prophylaxis per American College of Obstetricians and Gynecologists (the College) recommendations, prophylaxis per U.S. Preventive Services Task Force recommendations, and universal prophylaxis. We included the costs associated with aspirin, preeclampsia, preterm birth, and potential aspirin-associated adverse effects. TreeAge Pro 2011 was used to perform the analysis. RESULTS: The estimated rate of preeclampsia would be 4.18% without prophylaxis compared with 4.17% with the College approach in which 0.35% (n=14,000) of women receive aspirin, 3.83% with the U.S. Preventive Services Task Force approach in which 23.5% (n=940,800) receive aspirin, and 3.81% with universal prophylaxis. Compared with no prophylaxis, the U.S. Preventive Services Task Force approach would save $377.4 million in direct medical care costs annually, and universal prophylaxis would save $365 million assuming 4 million births each year. The U.S. Preventive Services Task Force approach is the most cost-beneficial in 79% of probabilistic simulations. Assuming a willingness to pay of $100,000 per neonatal quality-adjusted life-year gained, the universal approach is the most cost-effective in more than 99% of simulations. CONCLUSION: Both the U.S. Preventive Services Task Force approach and universal prophylaxis would reduce morbidity, save lives, and lower health care costs in the United States to a much greater degree than the approach currently recommended by the College.

Overview

Integrity signals

Registry

Crossref · 10.1097/aog.0000000000001115

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 76 references

Research works printed but not linked: 2

  1. Lethbridge-Cejku, 10, Summary health statistics for U.S. adults: National Health Interview Survey, 2002., Vital Health Stat, 2004, 1
  2. Martin, 2013, Births: final data for 2011., Natl Vital Stat Rep, 62, 1

Cited by

See all 113

Metadata

Authors
Werner, E. F., Hauspurg, A. K., & Rouse, D. J.
Affiliations
Brown University (US)
Venue
Obstetrics & Gynecology
Published
2015-12
Volume
126
Issue
6
Pages
1242-1250
ISSN
0029-7844 (ISSN-L)
OpenAlex
W2318239034
Cited by
113
References
82
Citations by year
2026: 6 · 2025: 11 · 2024: 6 · 2023: 14 · 2022: 12 · 2021: 9 · 2020: 10 · 2019: 12 · 2018: 10 · 2017: 11 · 2016: 9 · 2015: 2
FWCI
12.14
Type
journal article
Language
en
Open access
closed
Locations
  • Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
Keywords
low-dose aspirin, aspirin prophylaxis, preeclampsia prevention, cost-benefit analysis, cost-effectiveness, universal prophylaxis, USPSTF recommendations, preterm birth, health care costs, pregnant women
MeSH terms
Administration, Oral, Aspirin, Cost-Benefit Analysis, Decision Support Techniques, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Platelet Aggregation Inhibitors, Pre-Eclampsia, Pregnancy, Prenatal Care, United States, Health Care Costs, Models, Economic, Quality-Adjusted Life Years, Premature Birth

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. https://app.cochat.ai/papers/10.1097/aog.0000000000001115
The paper
Werner, E. F., Hauspurg, A. K., & Rouse, D. J. (2015). A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000001115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.